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Abstract: Treatment of rat brain membranes with the irre- 
versible opioid ligand cis-3-methylfentanylisothiocyanate 
(Superfit) was used to reduce gradually the number o,f avail- 
able binding sites for the &selective agonist [3H][D- 
Se8,Leu5]enkephalin-Thr6 ([3H]DSLET). Subsequently, the 
correlation between ligand binding and low-K, GTPase was 
investigated. Alkylation with 10 pMand 25 pM Superfit in- 
activated 66% and 71% of high-affinity (KD, 1 nM) binding 
sites without decreasing the affinity of the remaining sites 
and the stimulation of low-K,,, GTPase by DSLET. Following 
exposure of the membranes to 50 pM and 75 pM Superfit, 
ligand binding was confined to the low-affinity (KD, 20 nM) 
sites. In these membranes, the 6-agonists DSLET and [D- 
Pen2,~-Pen5]enkephalin still stimulated low-K, GTPase, and 
these effects were blocked by ICI 174864 (N,N-diallyl-Tyr- 
AIB-AIB-Phe-Leu-OH; AIB, a-aminoisobutyric acid), a 6- 
selective antagonist. A similar relationship between low-af- 
finity ligand binding and GTPase stimulation was observed 
following alkylation of the 6-opioid receptor with the non- 
selective irreversible antagonist P-chlornaltrexamine in the 
presence of protective concentrations of DSLET. The results 
reveal spare receptor sites in the coupling of the 6-opioid 
receptor to low-K, GTPase in brain and identify low-affinity 
ligand binding as a functional component in the process. Key 
Words: 6-Opioid receptor-GTP binding protein-Brain 
GTPase-Receptor-effector coupling-Rat brain mem- 
branes. Clark M. J. et al. Relationship between opioid-re- 
ceptor occupancy and stimulation of low-K, GTPase in brain 
membranes. J. Neurochem. 52, 1 162-1 169 (1989). 
On the basis of acute inhibition by opiates and a 
long-term compensatory increase in enzyme activity 
in NG108-15 neuroblastoma X glioma hybrid cells, 
the functional coupling of opioid receptor to aderiylate 
cyclase was proposed (Sharma et al., 1975a,b). That 
interaction has since been well documented both in 
neurally derived transformed cells (Blume et al., L979; 
Law et al., 1982) and in brain (Law et al., 1981; Barch- 
feld et al., 1982). In membrane preparations from these 
tissues, opiates stimulated a low-K, GTPase as part of 
the mechanism that links opioid receptor occupancy 
to adenylate cyclase inhibition (Koski and Klee, 198 1; 
Barchfeld and Medzihradsky, 1984). The enzymatic 
hydrolysis of GTP is an important step in the mech- 
anism by which GTP binding proteins regulate the 
coupling of membrane receptors to adenylate cyclase 
(Cassel and Selinger, 1978; Hildebrandt et al., 1083). 
Purified inhibitory GTP binding protein (Gi) lfrom 
brain has been shown to exhibit low-K, GTPase ac- 
tivity (Milligan and Klee, 1985). 
The effects of opioid agonists on adenylate cyclase 
and low-K, GTPase from brain displayed the major 
characteristics of ligand binding to opioid receptor: 
stereospecificity and inhibition by antagonists (Barch- 
feld et al., 1982; Barchfeld and Medzihradsky, 1984). 
However, information on the quantitative relationship 
between opioid receptor occupancy and effector re- 
sponses is spotty. Spare receptors in the inhibition of 
adenylate cyclase (Fantozzi et al., 1981) and cyclic 
AMP formation (Law et al., 1983) by opiates in the 
neuroblastoma X glioma NG 108- 15 hybrid cells were 
described, and different receptor reserves for dynorphin 
in guinea pig ileum and in mouse vas deferens were 
implied to explain the diverging potency of the opioid 
peptide in these tissues (Cox and Chavkin, 1983). With 
other receptor systems, the occupancy theory of effector 
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activation was shown clearly to represent just one of 
the existing relationships between the degree of receptor 
occupancy and tissue response: e.g., the inhibitory aZ- 
adrenergic receptor in human platelets (Lenox et al., 
1985), but not the stimulatory @-adrenergic receptor 
in S49 lymphoma cells (Mahan and Insel, 1985), were 
shown to have spare ligand binding sites in their cou- 
pling to adenylate cyclase. Furthermore, a markedly 
different receptor reserve was shown for coupling of 
the muscarinic receptors to adenylate cyclase and 
phosphoinositide hydrolysis, respectively (Brown and 
Goldstein, 1987). 
Following the characterization of the kinetics of li- 
gand binding to opioid receptors in brain membranes 
(Fischel and Medzihradsky, 198 1, 1986) and brain 
slices (Barchfeld-Rothschild and Medzihradsky, 1987), 
we have described the coupling of multiple opioid re- 
ceptors to brain GTPase (Clark et al., 1986; Clark and 
Medzihradsky, 1987) and adenylate cyclase (Barchfeld 
et al., 1982). In some of these studies, we have selec- 
tively alkylated opioid receptors to obtain brain mem- 
branes specific for a given type of receptor. In the pres- 
ent work, we have used progressive alkylation of the 
6-opioid receptor to study the efficacy of ligand binding 
in stimulating low-K,,, GTPase, a process underlying 
the inhibition of the putative effector, adenylate cyclase. 
In addition, we have evaluated the significance of high- 
and low-affinity ligand binding sites in receptor-effector 
coupling. Initial findings of this work have been pre- 
sented in a preliminary form (Clark and Medzihradsky, 
1986). 
MATERIALS AND METHODS 
Materials 
The &selective opiates, DPDPE ([~-Pen’,~-Pen’]enkeph- 
alin), ICI 174864 (NJ-diallyl-Tyr-AIB-AIB-Phe-Leu-OH; 
AIB, a-aminoisobutyric acid), and Superfit (cis-3-methyl- 
fentanylisothiocyanate), were obtained through the Narcotic 
Drug and Opioid Peptide Basic Research Center at the Uni- 
versity of Michigan. The nonselective-opioid antagonist, 8- 
CNA (P-chlornaltrexamine), was purchased from Research 
Biochemicals, Inc. (Wayland, MA, U.S.A.), and DSLET ([D- 
Se2,Leu5]enkephalin-Thr6) was bought from Cambridge Re- 
search Biochemicals (Atlantic Beach, NY, U.S.A.). [y- 
32P]GTP (25 Ci/mmol) and [3H]DSLET (30.5 Ci/mmol) were 
obtained from Amersham Corp. (Arlington Heights, IL, 
U.S.A.) and New England Nuclear Corp. (Boston, MA, 
U.S.A.), respectively. The biochemicals used in the GTPase 
assay were from Sigma Chemical Co. (St. Louis, 
MO, U.S.A.). 
Membrane preparation 
Membranes from the cerebrum of Sprague-Dawley rats 
weighing 200 g were isolated as described (Fischel and Med- 
zihradsky, 198 I ) .  The membranes were eventually sedi- 
mented at 20,000 g and suspended in Tris-HC1 (pH 7.4). 
Aliquots of this suspension, sufficient for experiments on one 
given day, were frozen at -70°C. Prior to use, the suspension 
was quickly thawed in a water bath and dispersed in a Dounce 
homogenizer. Protein concentration in the latter preparation 
was approximately 0.6 mg/ml. 
Receptor alkylation 
For direct alkylation (Clark and Medzihradsky, 1987), the 
suspension of cerebral membranes in Tris-HC1 (pH 7.4), ad- 
justed to a protein Concentration of 0.35 mg/ml, was incu- 
bated with different concentrations of Superfit for 40 rnin at 
25°C in a shaking water bath. After fivefold dilution with 
Tris-HC1 (pH 7.4), the suspension was centrifuged at 20,000 
g for 15 rnin at 4°C. The pellet was suspended, using a Dounce 
homogenizer, in five original volumes of the Tris buffer and 
centrifuged as described above. The procedure was repeated 
once more and the pellet suspended in the original volume 
of Tris-HC1 (pH 7.4). The adequacy of this washing procedure 
to remove unbound alkylator was ascertained by the con- 
stancy of [3H]DSLET binding parameters (KD, &,) after 
the third centrifugation; subsequent washes yielded super- 
imposable binding curves. The treated membranes either were 
used fresh or were frozen in aliquots at -70°C. The freezing 
had no detectable effects on the results. 
For protective alkylation (Clark and Medzihradsky, 1987), 
a suspension of cerebral membranes in Tris-HC1 buffer (pH 
7.4), adjusted to a protein concentration of 0.35 mg/ml, was 
incubated with 400 pM DSLET for 5 rnin at 25°C. After 
NaCl and &-CNA were added to a final concentration of 120 
mM and 25 pM, respectively, the suspension was incubated 
for 40 rnin at 25°C and then centrifuged at 20,000 g for 15 
min at 4°C. The pellet was washed by suspension and cen- 
trifugation as described above for the direct alkylation. Ali- 
quots of the membrane suspension were frozen at -7OOC. 
GTPase assay 
The experimental procedure used has been described pre- 
viously (Clark and Medzihradsky, 1987) and is based on the 
method of Cassel and Selinger ( 1  976). In principle, the hy- 
drolysis of [Y-~~PIGTP was measured in the presence of Mg2+ 
and an ATP regenerating system. The concentration of GTP 
was either 0.5 pM or 2 pM, the latter corresponding to the 
10-fold value of the low-affinity K, . In separate tubes, the 
reaction mixture also contained 50 pMGTP to measure the 
opiate-insensitive, high-K, GTPase activity. The latter was 
subtracted from total enzyme activity to yield the opiate- 
sensitive, low-K,,, GTPase activity. The following controls 
were included routinely in each assay: basal GTPase activity 
in the absence of opiates, GTP hydrolysis in the absence of 
membranes, and GTP hydrolysis in the assay medium prior 
to sample incubation. 
Determination of protein 
serum albumin as standard. 
Ligand binding 
The experimental procedure was described in detail pre- 
viously (Fischel and Medzihradsky, 198 1; Clark et al., 1988). 
The medium, dispensed to 8-ml polypropylene tubes, con- 
sisted of 185 pl of membrane suspension (24 pg of protein), 
25 pl of [3H]DSLET (to yield final concentrations of 0.2-60 
nM), 25 pl of unlabeled DSLET (to give a final concentration 
of 50 pA4) or HzO, and 25 pl of NaCl (final concentration 
120 W) or HzO. In some experiments, MgC12 and GTP 
were added together with the NaCl to give final concentrations 
of 5 W a n d  0.5 or 2 pM, respectively. In a few experiments, 
ligand binding was determined in the complete GTPase assay 
medium, excluding the radiolabeled nucleotide. Following 
incubation of the membrane suspension for 15 rnin at 25”C, 
the assay was started by the addition of radiolabeled and 
The method of Lowry et al. (195 1) was used, with bovine 
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unlabeled DSLET (the latter was added to the tubes used for 
the determination of specific binding). After incubation for 
65 min at 25°C to reach equilibrium in binding, the samples 
were quickly filtered and subjected to liquid scintiillation 
counting. Opioid receptor binding of [3H]DSLET was defined 
as the difference between ligand binding determined in the 
absence and presence of 50 PMunlabeled DSLET. Th' (is con- 
centration maximally displaced the total binding of 
[3H]DSLET at all the concentrations used in this study (data 
not shown). Also established and considered was the depen- 
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Statistical analysis of the data 
The data for ligand binding was fit to a receptor model 
with two saturable sites. The binding parameters were esti- 
mated by the weighted nonlinear least-square regression pro- 
gram, NONLIN (Metzler, 1969; Fischel and Medzihradsky, 
1981, 1986). Initial estimates for the parameters KDI, KDz, 
B,,,, , and Bmax2 were provided by a subroutine baseld on a 
partitioned reciprocal analysis that corrected for the mutual 
interaction between the high- and low-affinity binding com- 
ponents (Neal, 1972). Variability in parameter estimates 
(kSD) was computed from the variance-covariance matrix, 
and the residual sum of squares (RSS) from the regrtsion. 
For each experiment, the regression was repeated severall times 
using initial estimates in the range f5% of the apparent so- 
lution. The resulting estimates were then averaged to reduce 
bias due to convergence limits in the regression. 
To ascertain the experimental conditions under which the 
high-affinity sites of the receptors become blocked, the binding 
data for alkylated membranes were also fit by a one saturable 
site regression model. The corresponding RSS values for the 
two models were compared by the extra sum of squares F 
statistic: F = [(RSS, - RSS2)/2]/[RSS2/u], where u is the de- 
gree of freedom for the two-site model. 
Estimates for KD and B,,, for each binding site are highly 
correlated, and reliable values are difficult to obtain especially 
at low levels of binding (Figs. 1 and 2). Considering the par- 
ticular importance of B,,, in this work, the regression analysis 
for each experiment was repeated, constraining the param- 
eters KDI and KD2 to the values obtained with nonalkylated 
(control) membranes. By eliminating variability in KD values, 
the estimates of B,,, were improved (Table 2). The validity 
of this approach was confirmed by comparing the RSS of the 
unconstrained series (Table 1) with that of the constrained 
series using the variance ratio F statistic (Table 2). 
The stimulation of low-K, brain GTPase was characterized 
by the parameters K, and S,, . The ligand concentration at 
which half-maximal stimulation (Ks) occurred was obtained 
from log-probit plots, relating stimulation of basal enzyme 
activity to five different ligand concentrations. The K, esti- 
mates were derived from a linear regression analysis. Maximal 
stimulation of basal low-K, GTPase (Smax) was obtained with 
24 I I 
140+ 
FIG. 1. Equilibrium binding of [3H]DSLET following re- 
ceptor alkylation. Rat cerebral membranes were 
treated with Superfit at the indicated concentrations 
as described under Materials and Methods. Subse- 
quently, the specific equilibrium binding of [3H]DSLET 
in the presence of 120 mM NaCl was determined. The 
Scatchard plots were drawn using the mean values 
for KD and B,,, obtained by the constrained nonlinear 
regression analysis (Table 2). The curves for 10 pM 
and 25 fiM Superfit are not statistically different. Illus- 
trated in the inset is the distribution of actual data 
points of ligand binding around the computer-gener- 
ated saturation curve using the parameters listed in 
Table 2. To improve the lucidity of the graph, results 
obtained with only one of the alkylated membranes 
(50 pM Superfit) are contrasted with the control. 
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gradually increasing ligand concentrations as a well-defined 
upper limit of enzyme activity. Opioid agonists present at 
concentrations larger than that yielding S,,, progressively 
inhibited GTPase stimulation. Variability of K, and S,, was 
expressed as standard deviation of the mean determined from 
replicate experiments (Table 3). 
RESULTS 
The binding of [3H]DSLET to opioid receptor in 
cerebral membranes revealed two populations of sat- 
urable sites with KD values of 0.99 nM and 19.63 nM, 
respectively (Fig. 1 and Table 1). Incubation of the 
membranes with 10 puMSuperfit, an irreversible ligand 
at the 6-opioid receptor (Smith et al., 1985; Clark and 
Medzihradsky, 1987), blocked 78% of the binding sites 
for [3H]DSLET without raising the KD values of either 
the high- or low-affinity sites relative to the control 
(Table 1). Also unaltered by this level of alkylation 
were the parameters K, and S,,,, by which DSLET 
stimulated basal low-K, GTPase activity (Table 3). 
Treatment of the membranes with 25 pM Superlit ef- 
fectively blocked the high-affinity sites (Table 1); S,,, 
was unaltered, but the K, for DSLET stimulation of 
GTPase increased twofold (Table 3). Receptor alkyl- 
ation with 50 pM and 75 p M  Superfit abolished the 
FIG. 2. Equilibrium binding of r3H]DSLET in alkylated 
membranes: effects of Mg2+ and GTP. Rat cerebral 
membranes were treated with 0.1 p M  and 10 pM Su- 
perfit as described under Materials and Methods. 
Subsequently, equilibrium binding of r3H]DSLET in 
control and alkylated membranes was determined in 
the presence of 120 mM NaCI, 5 mM MgClp, and 0.5 
pM GTP, the concentrations present in the GTPase 
assay medium. The Scatchard plots were derived from 
the mean values for KD and B,,, obtained by the con- 
strained nonlinear regression analysis (Table 2). Shown 
in the inset is the distribution of actual data points of 
ligand binding around the computer-generated satu- 
ration curve drawn according to the parameters in Ta- 
ble 2. 
high-affinity sites of ligand binding and raised the KD 
of the low-affinity components (Fig. 1 and Table 1). In 
these membranes, DSLET still stimulated GTPase, al- 
though with deteriorating kinetic parameters (Table 
3). Enzyme activity was also enhanced by DPDPE, an 
opioid ligand of high 6 selectivity (Clark et al., 1988), 
with K, and S,,, values of 24 pMand 1 1 %, respectively. 
Confirming earlier results (Clark and Medzihradsky, 
1987), the stimulation by both DSLET and DPDPE 
was inhibited (data not shown) by ICI 174864, a 6- 
selective antagonist (Cotton et al., 1984). Finally, 100 
pM Superfit eliminated both high- and low-affinity li- 
gand-binding sites (Table l), and DSLET failed to 
stimulate GTPase activity (Table 3). 
By constraining the numerical values for KD, the 
significance of the data on the number of high- and 
low-affinity sites was enhanced (Table 2). The con- 
strained series also gave B,,, estimates that decreased 
with increasing Superfit concentrations, as expected by 
a priori reasoning. The absence of high-affinity sites 
described by regression was confirmed by the fit of the 
respective data to a one-site receptor model (Tables 1 
and 2). 
The 6-opioid receptor was also alkylated with the 
nonspecific irreversible opioid antagonist /3-CNA 
J Neurochem , Vol. 52,  N o  4. 19x9 
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TABLE 1. Parameters of[-'H]DSLET equilibrium binding and GTPase stimulation 
Binding parameted 
Membrane treatment Components added to - 
( p M  alkylator) binding assay" KD I KDZ Bmax I Bm-2 RSS n 
Superfit 
0 Na+ 0.99 (2  '0.22) 19.63 (+ 1.22) 13.93 (+ 2.44) 170.52 ( 2  1.97) 42.18 47 
10 Na' 0.25 (2 0.30) 13.63 (5 3.24) 3.65 (* 1.58) 36.63 (+ 1.42) 16.63 22 
25' Na* 1.14(+ 1.29) 21.30(+9.27) 4.58 (+ 3.82) 38.58 (+ 3.53) 19.06 22 
SOC Na+ 1.61 (* 7.37) 27.34 (5 6.79) 1.38 (t 2.69) 41.52 (? 3.13) 10.70 21 
7 s c  Na' N D ~  33.43 (+- 3.52) ND 45.69 (2  4.36) 21.08 21 
12 
0 Na', Mg2+, GTP 1.97 (2 0.46) 28.40 (-+ 11.48) 48.33 (+ 11.51) 136.71 (+ 12.85) 20.04 23 
0.1 Na+, Mg2+,GTP 1.49 (k 13.68) 38.81 (+ 7.60) 9.01 (+ 3.56) 171.94( t  13.24) 6.59 21 
45.05 (2 9.25) 6.23 16 
25 (+ 400 pM DSLET) Na+ ND 24.01 (+ 3.05) ND 61.20 (+ 5.62) 0.43 10 
8 25 Na+ ND ND ND ND - 
100 Na+ ND ND ND ND - 
1 0' Na', Mg2+, GTP 1.16 (2 5.73) 51.55 (2 22.78) 0.79 (+ 1.80) 
p-CNA' 
The binding parameters were obtained from an unconstrained nonlinear regression analysis using a receptor model with two or one binding site as described 
under Materials and Methods. Shown are parameter means, standard deviations, and total number ofdata points (n). RSS reflects the variability in the data remaining 
after the variability due to parameter effects is removed. RSS was typically I %  of the total sum of squares. 
'The concentrations of NaCI, MgC12, and GTP were I 2 0  mM, 5 nPM, and 0.5 pM, respectively. 
' KO and Bmax values are in  units of nM and fmol/mg of protein, respectively. 
The data also fit a one-site model. 
ND. not detectable. 
'These experiments were part of the first series shown in this table. with 0 Superfit as the appropriate control. 
(Ward et al., 1982) in the presence of 400 pM DSLET 
as the site-protective ligand (Table 1). The conctentra- 
tion of DSLET was selected to provide submaximal 
receptor protection. Following treatment, the charac- 
teristics of ligand binding and GTPase stimulation were 
indeed similar to those obtained by alkylation with 50 
pM or 75 pM Supedit: total ligand binding was reduced 
by 72% with only low-affinity sites for [3H]DSLET 
binding remaining (Tables 1 and 2), and DSLET still 
stimulated GTPase activity (Table 3). Again, this stim- 
ulation was inhibited by ICI 174864 (not shown). 
However, whereas protective alkylation with 7 5 pA4 
Superfit adversely affected the parameters of GTPase 
stimulation, these were similar to control values in 
membranes alkylated with P-CNA and DSLET (Table 
3). In membranes treated with p-CNA alone, saturable 
ligand binding and GTPase stimulation were unde- 
tectable. 
Na', Mg2+, and GTP are effective modulators of 
ligand binding to opioid receptor (Blume, 1978; Child- 
ers and Snyder, 1980), and Na' and GTP are essential 
for the coupling of opioid receptor to adenylate cyclase 
(Blume et al., 1979). Therefore, we have investigated 
the relationship between [ 3H]DSLET binding and 
TABLE 2. Statistical analysis of ligand binding 
Binding parameters' Statistical parameters 
Membrane treatment 








1 .oo 20.00 14.42 170.79 42.24 1.001 43 
1 .oo 20.00 4.87 39.52 19.08 1.147 18 
1 .oo 20.00 4.20 37.52 19.01 1.003 18 
1 .oo 20.00 0.05 37.86 I 1.05 1.033 17 
2.00 28.00 47.7 1 136.86 20.3 1 1.013 19 
2.00 28.00 5.52 150.36 7.40 1.123 17 
2.00 28.00 1.51 28.62 6.03 1.033 12 
As described under Materials and Methods, the parameters; listed below were estimated from a regression analysis with KD values constrained 
to the values obtained with nonalkylated membranes (Table I). Listed are the parameter estimates, the RSS, the F statistic calculated as the 
ratio of RSS values in Tables 2 and I ,  and the degrees of freedom ( v )  for the regression. 
Ku and B,.,, values are in units of nM and fmol/mg of protein, respectively. 
In  this series, 120 mM NaCl was present in the binding assay. 
' Data also fit a one-site model. 
,I In this series, 120 mM NaCI, 5 mM MgCIz, and 0.5 pM GTP were present in the binding assay. 
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25 (+400 ph4 DSLET) 
25 
5.6 f 0.8 
6.2 f 0.7 
6.2 f 1.5 
11.0 f 2.8 
55.0 & 7.4 
NDY 
6.5 f 1.1  
ND 
23 f 3 
22 f 2 
21 + 2  
1 9 + 2  
1 3 k 3  
N D  
2 9 &  13 
ND 
The assay of low-K, GTPase activity was carried out as described 
under Materials and Methods. Shown are K,, the concentrations of 
DSLET yielding half-maximal stimulation of basal enzyme activity, 
and S,.,, the maximal stimulation of basal GTPase activity expressed 
in percent. Basal enzyme activity (mean value 67 pmol/mg protein/ 
min) was not significantly affected by the alkylations. Listed are mean 
values and standard deviations obtained in three to five experiments 
carried out in triplicate. 
ND, not detectable. ' The appropriate control values are the data listed under 0 Superfit. 
GTPase stimulation in the presence of identical con- 
centrations of Na', Mg2+, and GTP (Fig. 2 and Table 
1). Under these conditions, the affinity of ligand bind- 
ing was decreased (Table 1). It was reduced further 
when binding was carried out in the GTPase assay me- 
dium containing 2 pM, rather than 0.5 pM, GTP: the 
KD values for [3H]DSLET were 4.2 nA4 and 54.4 nM, 
whereas the K, for DSLET was 0.6 pM. These exper- 
iments also revealed the effectiveness of Superfit at 
submicromolar concentrations: 0.1 pM alkylator re- 
duced high-affinity [3H]DSLET binding by 8 1 '% (Table 
1). Nonetheless, under the conditions of either partial 
or complete abolishment of high-affinity ligand bind- 
ing, either in the absence or presence of GTPase assay 
components, the stimulation of low-K, GTPase was 
indistinguishable from control (Table 3). 
DISCUSSION 
In a number of tissues and receptor systems, the 
total occupancy of ligand binding sites was found not 
to correlate with the maximum response at the effector 
level. For example, in human platelets, the elimination 
of 90% of a2-adrenergic receptor sites still produced 
half-maximal inhibition of cyclic AMP accumulation 
(Lenox et al., 1985), and maximal activation of glucose 
transport in adipocytes was obtained with about 5% of 
the high-affinity insulin receptor sites on the cell surface 
(Kono and Barham, 1971). However, the magnitude 
of receptor reserve in a tissue can be characteristic of 
a given ligand, and different at various degrees of re- 
ceptor response (Kenakin, 1986). The experimental 
approach frequently used to investigate the existence 
of spare receptors is to alter the number of receptor 
sites by their alkylation with irreversible ligands and 
to measure functional responses of one or more effector 
components (Brown and Goldstein, 1987) in one 
(Brown and Goldstein, 1987) or different (Mahan and 
Insel, 1985; Fisher and Snyder, 1987) tissues. These 
studies described different muscarinic receptor reserves 
in various brain regions and cloned neural cells (Fisher 
and Snyder, 1987), and, most interestingly, for two ef- 
fector processes in chick heart cells (Brown and Gold- 
stein, 1987). Opioid receptor reserves were implicated 
in smooth muscle preparations (Cox and Chavkin, 
1983), and alkylation by P-CNA of 95% of opiate bind- 
ing sites in NG108-15 hybrid cells did not alter the 
extent of inhibition of adenylate cyclase (Fantozzi et 
al., 1981). In these cells, the ratio of& of ligand bind- 
ing and Ki to inhibit adenylate cyclase was used to de- 
scribe spare receptor sites for some, but not all, opiates 
investigated (Law et al., 1983). In a recent preliminary 
study, both irreversible opioid ligands and exposure of 
NG108-15 cells to phospholipase were used to dem- 
onstrate continued inhibition of adenylate cyclase by 
opiates despite the substantial decrease in ligand bind- 
ing (Childers et al., 1986). 
In rat cerebral membranes, Scatchard analysis of li- 
gand binding at equilibrium and assessment of the as- 
sociation and dissociation kinetics (Fischel and Med- 
zihradsky, 1981, 1986) have shown the existence of 
two populations of saturable opioid receptor sites with 
different binding affinities. Such biphasic binding was 
described for both opioid agonists (Childers and Sny- 
der, 1980; Nishimura et al., 1984; Fischel and Med- 
zihradsky, 1986) and antagonists (Childers and Snyder, 
1980; Fischel and Medzihradsky, 198 1; Roth and Cos- 
cia, 1984), and shown by computer fitting to corre- 
spond to a minimal model of two saturable binding 
sites (Fischel and Medzihradsky, 198 1). 
In the present study, the specific binding of 
[3H]DSLET in the presence of Na' was best described 
by interaction with two populations of binding sites 
with KD values of 1 nA4 and 20 nM. In coupling to 
brain GTPase, there was a large excess of receptor sites: 
occupancy of approximately 20% was sufficient to pro- 
duce maximal stimulation of enzyme activity. Specif- 
ically, following the preferential alkylation of the high- 
affinity sites, GTPase was stimulated apparently by li- 
gand binding to the low-affinity sites. Further alkylation 
eventually abolished both specific ligand binding and 
receptor-GTPase coupling. The number of 6-ligand 
binding sites was also altered by the approach of pro- 
tective alkylation. Following treatment with P-CNA in 
the presence of DSLET, only low-affinity binding sites 
of [3H]DSLET remained, and their occupancy by 
DSLET stimulated GTPase. The absence of high-affin- 
ity ligand binding was confirmed by rigorous statistical 
analysis. Such treatment of the data was particularly 
important in view of the increased variability of ligand 
binding in alkylated membranes with a diminished 
number of receptor sites. 
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The 6 selectivity of the low-affinity sites was ascer- 
tained by two criteria using highly selective ligands 
(Clark et al., 1988): in alkylated membranes with only 
these sites present, the &-opiates DSLET and DPDPE 
stimulated GTPase, and these effects were blocked by 
the 6-antagonist ICI 174864. As shown recently, this 
compound inhibited GTPase stimulation by 6- lbut not 
by p- or K-opioid agonists (Clark and Medzihradsky, 
1987). 
Under any of the employed experimental conditions, 
maximal coupling of the 6-opioid receptor to low-K, 
GTPase occurred at submaximal receptor occupancy, 
and enzyme activity was stimulated in the absence of 
high-affinity ligand binding sites. In the presence of 
Na+, Mg2+, and GTP, the difference between the values 
for KD and K, decreased, and became even smaller if 
ligand binding was carried out under conditions iden- 
tical to those of the GTPase assay. The proposition 
that optimal coupling between the opioid receptor and 
brain GTPase requires an intact membrane and/or 
cellular microenvironment, disrupted by the process 
of membrane isolation, is supported by the strongly 
impaired inhibition of adenylate cyclase by opioid ag- 
onists in brain membranes, in contrast to intact cells 
(Barchfeld et al., 1982). The dependence of opioid re- 
ceptor mechanisms on the structural and dynamic 
characteristics of the plasma membranes has belen as- 
certained and is presently under investigation (Med- 
zihradsky, 1989). 
Of particular interest in the present work is the ap- 
parent functional role of the low-affinity binding com- 
ponent. In intact cells, the muscarinic acetylcholine 
receptor (Nathanson, 1983) and 6-adrenergic receptor 
(Pittman and Molinoff, 1980) were present as a :single 
population of binding sites with affinities similar to 
those of the low-affinity component of these receptors 
measured in isolated membranes. To explain these 
findings, the presence in intact cells of two rapidly in- 
terconverting forms of the receptor or a single low- 
affinity form regulated by intracellular GTP was pro- 
posed (Nathanson, 1983). In our work, the presence 
of 0.5 pM GTP decreased the affinity of both receptor 
binding components (Table I), and 2 pM GTP-7-S 
markedly reduced the number of high-affinity opioid 
receptor sites (Remmers and Medzihradsky, 1987). 
Furthermore, the EC50 values for the displacement of 
[3H]etorphine by opiates in slices, but not in isolated 
membranes, from rat brain striatum were similar to 
the respective ECso values of these compounds in in- 
hibiting adenylate cyclase (Barchfeld-Rothschild and 
Medzihradsky, 1987). Thus, our data seem to support 
the hypothesis that, in contrast to cellular preparations, 
the 6-opioid receptor in isolated membranes is present 
to a large extent in an uncoupled high-affinity form. It 
was suggested previously that the high-affinity receptor 
sites observed following cell disruption are not fully 
subject to regulation by guanine nucleotides (Nathan- 
son, 1983). On the other hand, as shown with the @- 
adrenergic receptor in rat reticulocytes, even in well- 
preserved intact cells a small fraction of high-affinity 
sites can be demonstrated along with the predominant 
low-affinity forms (Porzig, 1982). In our study, the 6- 
opioid receptor in isolated brain membranes showed 
strong sensitivity toward components of the GTPase 
assay medium, including GTP. In freshly prepared 
membranes suspended in such a medium at 37"C, the 
difference between the K D  value of ligand binding and 
K, of low-K, GTPase stimulation was markedly de- 
creased. These results are now being complemented by 
the assessment of opioid receptor-effector coupling in 
primary neuronal cultures. 
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